Evidence-Based Reviews

Second of 2 parts: A practical approach to subtyping depression among your patients

Current Psychiatry. 2014 May;13(5):41-46

References

1. Fergusson DM, Horwood LJ, Ridder EM, et al. Subthreshold depression in adolescence and mental health outcomes in adulthood. Arch Gen Psychiatry. 2005;62(1):66-72.
2. Mitchell PB, Parker GB, Gladstone GL, et al. Severity of stressful life events in first and subsequent episodes of depression: the relevance of depressive subtypes. J Affect Disord. 2003;73(3):245-252.
3. Coryell W, Winokur G, Maser JD, et al. Recurrently situational (reactive) depression: a study of course, phenomenology and familial psychopathology. J Affect Disord. 1994;31(3):203-210.
4. Slotema CW, Blom JD, Hoek HW, et al. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(7):873-884.
5. Kendler KS. The diagnostic validity of melancholic major depression in a population-based sample of female twins. Arch Gen Psychiatry. 1997;54(4):299-304.
6. Bracht T, Horn H, Strik W, et al. White matter microstructure alterations of the medial forebrain bundle in melancholic depression. J Affect Disord. 2014;155:186-193.
7. Pizzagalli DA, Oakes TR, Fox AS, et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry. 2004;9(4):325, 393-405.
8. Melartin T, Leskelä U, Rytsälä H, et al. Co-morbidity and stability of melancholic features in DSM-IV major depressive disorder. Psychol Med. 2004;34(8):1443-1452.
9. Caldieraro MA, Baeza FL, Pinheiro DO, et al. Prevalence of psychotic symptoms in those with melancholic and nonmelancholic depression. J Nerv Ment Dis. 2013;201(10):855-859.
10. Grunebaum MF, Galfalvy HC, Oquendo MA, et al. Melancholia and the probability and lethality of suicide attempts. Br J Psychiatry. 2004;184:534-535.
11. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry. 1994;151(12):1735-1739.
12. Koukopoulos A, Sani G, Koukopoulos AE, et al. Melancholia agitata and mixed depression. Acta Psychiatr Scand Suppl. 2007;(433):50-57.
13. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008; 165(3):342-351.
14. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170(1):59-70.
15. Rush AJ, Trivedi MH, Carmody TJ, et al. Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline. Neuropsychopharmacology. 2001;25(1):131-138.
16. Rasmussen KG, Snyder KA, Knapp RG, et al. Relationship between somatization and remission with ECT. Psychiatry Res. 2004;129(3):293-295.
17. Henkel V, Mergl R, Allgaier AK, et al. Treatment of depression with atypical features: a meta-analytic approach. Psychiatry Res. 2006;141(1):89-101.
18. Husain MM, McClintock SM, Rush AJ, et al. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry. 2008;69(3):406-411.
19. Iovieno N, Tedeschini E, Bentley KH, et al. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72(8):1144-1151.
20. Pedrelli P, Iovieno N, Vitali M, et al. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis. J Clin Psychopharmacol. 2011;31(5):582-586.
21. Pearlstein TB, Stone AB, Lund SA, et al. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol. 1997;17(4):261-266.
22. Freeman EW, Rickels K, Sondheimer SJ, et al. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry. 1999;56(10):932-939.
23. Krasnik C, Montori VM, Guyatt GH, et al. The effect of bright light therapy on depression associated with premenstrual dysphoric disorder. Am J Obstet Gynecol. 2005;193(3, pt 1):658-661.
24. Thaler K, Delivuk M, Chapman A, et al. Second-generation antidepressants for seasonal affective disorder. Cochrane Database Syst Rev. 2011;7(12):CD008591.
25. Thalén BE, Kjellman BF, Mørkid L, et al. Light treatment in seasonal and nonseasonal depression. Acta Psychiatr Scand. 1995;91(5):352-360.

Second of 2 parts: A practical approach to subtyping depression among your patients

References

Pages

Recommended Reading

Related Articles

Evidence-Based Reviews

The first of 2 parts: A practical approach to subtyping depression among your patients

From the Editor

Misdiagnosing bipolar depression as major depressive disorder